… patients with:
• hypersensitivity to dihydropyridine derivatives, Amlodipine or to any of the excipients listed in section 6.1.
• severe hypotension.
• shock (including cardiogenic shock).
• obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).
• haemodynamically unstable heart failure after acute myocardial infarction.
Identical in all 4 labels. Surrounding text shown from Ipca Laboratories UK Ltd.
… in patients with:
- hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients listed in section 6.1
-
- severe hypotension
- shock (including cardiogenic shock)
- obstruction of the outflow tract of the left ventricle (e.g. high grade aortic stenosis)
- haemodynamically unstable heart failure after acute myocardial infarction
Identical in all 3 labels. Surrounding text shown from Sandoz Limited.
… indicated in patients with:
Hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients listed in section 6.1.
Severe hypotension.
Shock (including cardiogenic shock).
Obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).
Haemodynamically unstable heart failure after acute myocardial infarction
Identical in both labels. Surrounding text shown from Flamingo Pharma (UK) Ltd.
… patients with:
• Hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients listed in section 6.1.
• Severe hypotension.
• Shock (including cardiogenic shock).
• Obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis). haemodynamically unstable heart failure after acute myocardial infarction
… s with:
• hypersensitivity to the active substance, dihydropyridine derivatives or to any of the excipients listed in section 6.1
• severe hypotension
• shock (including cardiogenic shock)
• obstruction of the outflow tract of the left ventricle (e.g. high-grade aortic stenosis)
• haemodynamically unstable heart failure after acute myocardial infarction
… in patients with:
• Hypersensitivity to dihydropyridine derivatives, amlodipine or any of the excipients listed in section 6.1.
• Severe hypotension.
• Shock (including cardiogenic) shock.
• Obstruction of the outflow-tract of the left ventricle (e.g. high grade aortic stenosis).
• Haemodynamically unstable heart failure after acute myocardial infarction.
… indicated in patients with:
hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients listed in section 6.1.
severe hypotension.
shock (including cardiogenic shock).
obstruction of the outflow tract of the left ventricle (e.g. high grade aortic stenosis).
haemodynamically unstable heart failure after acute myocardial infarction.